Replies to post #151754 on Biotech Values

[ghmm]

BMRN:

I would have been worried if that arm did better than the weekly. They also pointed out that longer term data showed continued improvement. My sense given the half life is that patients need more drug. I believe one of the studies ongoing is using an even higher dose.